揚科集團(01460.HK)年度溢利2272.7萬港元 同比增長20%
格隆匯6月29日丨揚科集團(01460.HK)公吿,截至2023年3月31日止年度的年度業績,收入8.77億港元,同比增長23%;年度溢利2272.7萬港元,同比增長20%;每股盈利1.2港仙。董事會不建議派付截至2023年3月31日止年度的任何末期股息。
集團收入增加主要由於(i)資訊科技基礎設施解決方案服務分部;(ii)資訊科技借調服務分部及(iii)資訊科技維護及支援服務分部產生的收入分別增加約2億港元、約420萬港元及約1760萬港元。這被資訊科技應用及解決方案開發服務分部產生的收入減少約5710萬港元所抵銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.